⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GCTK News
GlucoTrack, Inc. Common Stock
Form 8-K
sec.gov
GCTK
Form 8-K
sec.gov
GCTK
Glucotrack, Inc. Announces Reverse Stock Split
businesswire.com
GCTK
Form 8-K
sec.gov
GCTK
Form 8-K/A
sec.gov
GCTK
Form 8-K
sec.gov
GCTK
Form 8-K
sec.gov
GCTK
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
businesswire.com
GCTK
Form 8-K
sec.gov
GCTK
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
businesswire.com
GCTK